Sandra Pohl

University Medical Center Hamburg-Eppendorf

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2024

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Zsuzsa Jenei-Lanzl

University Hospital Frankfurt

GERMANY

View details

Lutz Fleischhauer

Munich University of Applied Sciences

GERMANY

View details

Thorsten Schinke

University Medical Center Hamburg-Eppendorf

GERMANY

View details

J. Simon Wiegert

University Medical Center Hamburg-Eppendorf

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sandra Pohl

Research Interests

Explore related searches

Contact this professor

Articles (8)

O-GlcNAcylation in the osteoblast lineage—boosting the complexity of Wnt-stimulated bone formation

CNS Manifestations in Mucolipidosis Type II—A Retrospective Analysis of Longitudinal Data on Neurocognitive Development and Neuroimaging in Eleven Patients

Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III

Imbalanced cellular metabolism compromises cartilage homeostasis and joint function in a mouse model of mucolipidosis type III gamma.

Distinct Modes of Balancing Glomerular Cell Proteostasis in Mucolipidosis Type II and III Prevent Proteinuria.

Hip Morphology in Mucolipidosis Type II

Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes.

Combined in vitro and in silico analyses of missense mutations in GNPTAB provide new insights into the molecular bases of mucolipidosis II and III alpha/beta

Collaborators (4)

Zsuzsa Jenei-Lanzl

Lutz Fleischhauer

Thorsten Schinke

J. Simon Wiegert

Make your next move.